Alzheimer's disease. A firm base for drug development

Nature. 1999 Dec 2;402(6761):471-2. doi: 10.1038/44973.
No abstract available

Publication types

  • Comment
  • News

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / enzymology
  • Amyloid Precursor Protein Secretases
  • Amyloid beta-Peptides / metabolism
  • Aspartic Acid Endopeptidases / antagonists & inhibitors*
  • Aspartic Acid Endopeptidases / isolation & purification
  • Aspartic Acid Endopeptidases / metabolism
  • Endopeptidases
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use*
  • Humans

Substances

  • Amyloid beta-Peptides
  • Enzyme Inhibitors
  • Amyloid Precursor Protein Secretases
  • Endopeptidases
  • Aspartic Acid Endopeptidases
  • BACE2 protein, human
  • BACE1 protein, human